共 50 条
- [1] Long-term safety and efficacy of rotigotine in idiopathic RLS: 3-year results from a multinational, open-label trial[J]. JOURNAL OF SLEEP RESEARCH, 2008, 17 : 113 - 113Garcia-Borreguero, D.
- [2] Long-term safety and efficacy of transdermal rotigotine in idiopathic RLS: 3-year results from a multinational open-label trial[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 110 - 110Garcia-Borreguero, D.Poewe, W.Hoegl, B.Kohnen, R.Stiasny-Kolste, K.Keffel, J.Schollmayer, E.Boroojerdi, B.Trenkwalder, C.Oertel, W. H.
- [3] Long-Term Safety and Efficacy of Rotigotine in Patients with Idiopathic RLS: 5-Year Results from a Prospective Multinational Open-Label FollowUp Study[J]. NEUROLOGY, 2010, 74 (09) : A106 - A106Hogl, BirgitTrenkwalder, ClaudiaGarcia-Borreguero, DiegoKohnen, RalfPoewe, WernerStiasny-Kolster, KarinBauer, LarsFichtner, AndreasSchollmayer, ErwinOertel, Wolgang
- [4] Long-term safety and efficacy of rotigotine in patients with idiopathic RLS: 5-year results front a prospective multinational open-label follow-up study[J]. MOVEMENT DISORDERS, 2010, 25 (07) : S517 - S517Hogl, I.Trenkwalder, C.Garcia-Borreguero, D.Kohnen, R.Poewe, W.Stiasny-Kolster, K.Bauer, L.Fichtner, A.Schollmayer, E.Oertel, W.
- [5] LONG-TERM TREATMENT WITH TRANSDERMAL ROTIGOTINE IN PATIENTS WITH IDIOPATHIC RESTLESS LEGS SYNDROME (RLS): RESULTS FROM A 12-MONTH OPEN-LABEL EXTENSION TRIAL[J]. SLEEP, 2010, 33 : A251 - A251Allen, R. P.Winkelman, J.Ondo, W.Fichtner, A.Schollmayer, E.
- [6] Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial[J]. EPILEPSY RESEARCH, 2020, 166Arnold, StephanLaloyaux, CedricSchulz, Anne-LivElmoufti, SamiYates, StephenFakhoury, Toufic
- [7] Long-term safety and efficacy of add-on cannabidiol for tuberous sclerosis complex-associated seizures: 3-year results from an open-label extension trial[J]. EPILEPSIA, 2023, 64 : 289 - 290Sahebkar, F.Thiele, E. A.Bebin, E. M.Filloux, F.Jansen, F. E.Kwan, P.Loftus, R.Sparagana, S.Lawson, J.Wheless, J.
- [8] Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (04) : 863 - 874Fleischer, David M.Shreffler, Wayne G.Campbell, Dianne E.Green, Todd D.Anvari, SaraAssa'ad, AmalBegin, PhilippeBeyer, KirstenBird, J. AndrewBrown-Whitehorn, TerriByrne, AideenChan, Edmond S.Cheema, AmarjitChinthrajah, SharonChong, Hey JinDavis, Carla M.Ford, Lara S.Gagnon, RemiGreenhawt, MatthewHourihane, Jonathan O'BJones, Stacie M.Kim, Edwin H.Lange, LarsLanser, Bruce J.Leonard, StephanieMahler, VeraMaronna, AndreasNowak-Wegrzyn, AnnaOriel, Roxanne C.O'Sullivan, MichaelPetroni, DanielPongracic, Jacqueline A.Prescott, Susan L.Schneider, Lynda C.Smith, PeterStaab, DorisSussman, GordonWood, RobertYang, William H.Lambert, RomainPeillon, AurelieBois, TimotheeSampson, Hugh A.
- [9] Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study[J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (06): : 445 - 453Trauner, MichaelNevens, FrederikShiffman, Mitchell L.Drenth, Joost P. H.Bowlus, Christopher L.Vargas, VictorAndreone, PietroHirschfield, Gideon M.Pencek, RichardMalecha, Elizabeth SmootMacConell, LeighShapiro, David
- [10] Augmentation of restless legs syndrome (RLS) under rotigotine: Results from a 5-year prospective, multinational, open-label study[J]. MOVEMENT DISORDERS, 2011, 26 : S361 - S361Kohnen, R.Garcia-Borreguero, D.Benes, H.Ferini-Strambi, L.Hoegl, B.Oertel, W.Trenkwalder, C.Fichtner, A.Schollmayer, E.